Jayarama Reddy*, Niranjan, V**
*St. Joseph’s Post Graduate Centre, 36, Langford Road, Bangalore – 560027, India.
**Outsourse Bioinformatics, R.A.Puram, Chennai-600028, India.
*corresponding authors
ABSTRACT
Swine influenza virus (SIV) is any strain of the influenza family of viruses that is endemic in pigs. Swine influenza is known to be caused by influenza A subtypes H1N1, H1N2, H2N3, H3N1, and H3N2. Swine influenza is an infection by any one of several types of swine influenza virus. Most work has been carried out in the European and American Populations which may or may not be effective in our tropical Indian Climate. Hence, further research is needed. Also, the research done has yielded a vaccine that is not known to be effective enough. Influenza research involves investigating molecular virology, pathogenesis, host immune responses, genomics and epidemiology. The main goal of this research is to develop vaccine for Indian influenza A virus using in-silico approach involving the following steps. Firstly, More than 1 lakh sequenced influenza A genomic segments were taken for finding the consensus sequence, as these would be the potential pathogenic segments for which vaccine development have to be raised. The consensus sequence at the nucleotide level were translated to the proteomic level. The consensus were further analyzed for its antigenic properties. The Consensus antigenic peptides which had interacted with human receptors were taken and analysed for mutations. Those segments without mutation would be the peptides of interest for the vaccine development and this is further analyzed for its sub cellular localization. Based on all of the above filters, we found 16 novel proteins identified with this consensus sequence which may be of interest for finding the novel gene in influenza A. At the same time, four novel genes are predicted with the consensus antigenic peptide motif from the Indian genomic segments which can be further explored for therapeutic interest.
KEYWORDS: vaccine, swine flu, epidemiology, immunogenicity, antigen.